# Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy

> **NCT03498417** · — · COMPLETED · sponsor: **University of Pisa** · enrollment: 135 (actual)

## Conditions studied

- Graves Ophthalmopathy
- Graves Disease
- Autoimmune Thyroiditis

## Interventions

- **DIAGNOSTIC_TEST:** Serum antibodies against the IGF-1R

## Key facts

- **NCT ID:** NCT03498417
- **Lead sponsor:** University of Pisa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-20
- **Primary completion:** 2018-07-20
- **Final completion:** 2018-07-20
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03498417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03498417, "Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03498417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*